₹ 0.29
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Biogen Pharmachem Industries Ltd. began its operations on July 13, 1995, from its headquarters in Rajkot, India. The company's main business activity focuses on dealing in and trading various shares and securities.
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITD.
Data is available to registered users only